use
distinct
separ
pneumonia
infect
lung
parenchyma
thu
distinct
infect
limit
trachea
larg
bronchi
chapter
acquir
commun
communityacquir
pneumonia
aris
institut
set
second
group
compos
hospitalacquir
pneumonia
ventilatorassoci
pneumonia
health
careassoci
pneumonia
two
major
pneumonia
categori
consid
separ
chapter
addit
consider
given
pneumonia
caus
recurr
aspir
oropharyng
content
term
pneumonia
howev
includ
caus
inflamm
lower
respiratori
air
space
particularli
alveoli
acut
chronic
eosinophil
pneumonia
cryptogen
organ
pneumonia
usual
interstiti
pneumonia
present
detail
elsewher
chapter
communityacquir
pneumonia
includ
case
infecti
pneumonia
patient
live
independ
commun
patient
hospit
reason
less
hour
develop
respiratori
symptom
also
consid
communityacquir
pneumonia
like
inocul
occur
admiss
howev
patient
previous
hospit
least
day
within
day
infect
patient
nurs
home
receiv
intraven
antibiot
therapi
chemotherapi
wound
care
within
past
day
patient
hemodialysi
center
consid
health
careassoci
pneumonia
therefor
exclud
case
definit
communityacquir
pneumonia
patient
contract
pneumonia
hour
institut
endotrach
intub
mechan
ventil
also
exclud
inasmuch
consid
ventilatorassoci
pneumonia
distinct
import
help
defin
like
infecti
agent
henc
strongli
influenc
appropri
choic
initi
antibiot
therapi
million
case
infecti
pneumonia
occur
annual
unit
state
result
million
hospit
pneumonia
lead
caus
death
worldwid
sixth
lead
caus
death
unit
state
common
lethal
infecti
diseas
mortal
rate
associ
communityacquir
pneumonia
rang
less
mildli
ill
outpati
somewhat
greater
overal
patient
admit
hospit
mortal
even
greater
patient
sever
invas
diseas
often
associ
bacteremia
elderli
nurs
home
patient
mortal
pneumonia
exceed
patient
requir
manag
intens
care
unit
icu
cost
approxim
manag
uncompl
case
pneumonia
hospit
treat
outpati
set
common
mechan
lung
inocul
pathogen
organ
microaspir
oropharyng
content
process
occur
otherwis
healthi
individu
sleep
chapter
colon
oral
pharynx
pathogen
organ
streptococcu
pneumonia
chapter
therebi
lead
deliveri
suffici
quantiti
organ
infect
lung
contrast
gross
aspir
normal
occur
individu
alter
sensorium
depress
conscious
abnorm
protect
cough
gag
reflex
substanti
gastroesophag
reflux
gross
aspir
also
deliv
larg
number
anaerob
bacteria
lower
respiratori
tract
major
contribut
factor
anaerob
lung
infect
abscess
format
chapter
second
frequent
mechan
lung
infect
inhal
small
suspend
aerosol
droplet
rang
size
may
contain
microorgan
view
limit
number
organ
deliv
manner
rel
aggress
pathogen
organ
mycobacterium
tuberculosi
chapter
legionella
pneumophila
chapter
yersinia
pesti
plagu
chapter
bacillu
anthraci
anthrax
chapter
viral
infect
transmit
manner
less
commonli
lung
may
becom
infect
consequ
blood
stream
infect
bloodborn
pneumonia
seen
especi
staphylococc
sepsi
chapter
rightsid
endocard
chapter
common
intraven
drug
user
chapter
gramneg
bacteremia
particularli
immunocompromis
host
lung
may
also
rare
inocul
directli
penetr
chest
trauma
local
spread
nearbi
infect
organ
bacteri
amoeb
liver
abscess
paragonimiasi
chapter
contigu
soft
tissu
infect
fortun
lung
well
equip
defend
inocul
microb
larg
droplet
infect
materi
reach
airway
remov
mucociliari
escal
sweep
entrap
content
oropharynx
swallow
expector
smaller
particl
rang
deposit
alveoli
alveolar
macrophag
phagocyt
destroy
pathogen
macrophag
activ
releas
potent
cytokin
chemokin
includ
tumor
necrosi
leukotrien
b
help
recruit
neutrophil
blood
stream
alveolar
space
particip
uptak
degrad
microorgan
mani
microorgan
pneumonia
chapter
clearanc
infect
greatli
facilit
develop
specif
immunoglobulin
g
bind
surfac
organ
polysaccharid
capsul
specif
antibodi
act
immun
opsonin
greatli
augment
abil
neutrophil
macrophag
phagocyt
destroy
bacteria
addit
pattern
recognit
receptor
nonimmun
opsonin
includ
surfact
protein
fibronectin
vitronectin
also
bind
specif
epitop
surfac
organ
reach
lower
respiratori
tract
assist
recognit
elimin
organ
overwhelm
evad
multipl
host
defens
system
inocul
lung
result
clinic
signific
pneumonia
possibl
pneumonia
consid
patient
new
respiratori
symptom
includ
cough
sputum
dyspnea
particularli
symptom
accompani
fever
abnorm
physic
examin
chest
rhonchi
rale
initi
manifest
frequent
subtl
patient
elderli
alter
immunolog
statu
patient
nonspecif
symptom
includ
loss
appetit
confus
dehydr
worsen
symptom
sign
chronic
ill
failur
thrive
may
initi
manifest
pneumonia
pneumonia
also
increasingli
preval
patient
specif
comorbid
condit
includ
smoke
chronic
obstruct
pulmonari
diseas
copd
chapter
diabet
mellitu
malign
heart
failur
neurolog
diseas
narcot
alcohol
use
chronic
liver
diseas
initi
symptom
sign
often
variabl
patient
patient
reliabl
use
establish
specif
microbiolog
diagnosi
classic
physic
find
lobar
pneumonia
includ
evid
consolid
alter
transmiss
breath
sound
egophoni
crackl
chang
tactil
fremitu
howev
mani
patient
physic
find
subtler
may
limit
scatter
rhonchi
thorough
physic
examin
posteroanterior
later
chest
radiograph
blood
leukocyt
count
differenti
cell
count
perform
pneumonia
suspect
assess
ga
exchang
oximetri
arteri
blood
ga
determin
obtain
patient
admit
hospit
clinician
need
mind
compet
diagnos
mimic
find
pneumonia
pulmonari
embol
chapter
bronchogen
bronchoalveolar
carcinoma
chapter
druginduc
lung
diseas
chapter
idiopath
interstiti
lung
diseas
chapter
even
intens
laboratori
investig
specif
microbiolog
caus
establish
certainti
approxim
patient
pneumonia
probabl
predomin
organ
vari
host
epidemiolog
factor
sever
ill
laboratori
approach
use
establish
diagnosi
pneumonia
chapter
organ
frequent
detect
cultur
sputum
blood
contrast
mycoplasma
pneumonia
chapter
frequent
detect
serolog
test
addit
bacteri
agent
includ
haemophilu
influenza
chapter
staphylococcu
aureu
chapter
enter
gramneg
bacilli
chapter
l
pneumophila
chapter
chlamydia
respiratori
virus
also
implic
case
socal
atyp
pathogen
includ
pneumonia
chlamydia
pneumonia
legionella
speci
increasingli
recogn
import
preval
caus
pneumonia
mix
infect
particularli
relat
coinfect
atyp
pathogen
addit
usual
bacteri
pathogen
report
one
third
patient
lower
respiratori
tract
infect
specif
host
factor
also
influenc
rel
risk
infect
specif
microorgan
tabl
instanc
smoker
copd
increas
risk
invas
pneumonia
well
h
influenza
moraxella
catarrhali
chapter
legionella
speci
alcohol
associ
increas
risk
drugresist
pneumonia
anaerob
lung
infect
tuberculosi
clinician
also
solicit
inform
household
workplac
exposur
ill
person
clinician
ask
recent
travel
specif
geograph
region
central
unit
state
histoplasmosi
endem
chapter
southwest
coccidioidomycosi
found
chapter
select
northern
central
region
unit
state
blastomycosi
found
chapter
recent
travel
region
epidem
viral
respiratori
infect
includ
season
influenza
avian
influenza
swine
influenza
sever
acut
respiratori
syndrom
sar
travel
asia
africa
central
eastern
europ
highli
endem
tuberculosi
consid
chapter
addit
environment
exposur
bird
psittacosi
bird
drop
histoplasmosi
bat
histoplasmosi
rabbit
tularemia
chapter
farm
anim
q
fever
chapter
addit
data
obtain
histori
although
attent
tradit
focus
bacteri
caus
sever
communityacquir
pneumonia
virus
also
caus
seriou
lower
respiratori
tract
infect
predomin
respiratori
virus
caus
sever
pneumonia
includ
variou
influenza
virus
respiratori
syncyti
viru
rsv
chapter
influenza
viru
rsv
detect
respiratori
secret
obtain
suspect
case
estim
influenza
infect
respons
excess
respiratoryand
circulatoryrel
death
annual
unit
state
predominantli
elderli
patient
underli
cardiopulmonari
metabol
diseas
influenzaassoci
pneumonia
consid
differenti
diagnosi
respiratori
infect
highrisk
patient
underli
diseas
resid
nurs
home
chronic
care
facil
season
octob
may
especi
patient
receiv
appropri
vaccin
also
increasingli
appreci
rsv
parainfluenza
chapter
virus
although
formerli
consid
mainli
infect
pediatr
popul
lead
seriou
lower
respiratori
tract
infect
adult
winter
season
host
immun
rsv
infect
childhood
incomplet
recurr
infect
occur
immunecompet
immuneimpair
adult
particularli
elderli
patient
estim
rsv
associ
death
year
unit
state
death
occur
elderli
peopl
patient
chronic
cardiopulmonari
diseas
emerg
influenza
infect
must
also
consid
although
typic
season
influenza
tend
occur
north
america
month
octob
may
novel
influenza
virus
alway
follow
epidemiolog
particular
spring
summer
novel
swine
influenza
viru
occur
epidem
proport
mexico
rapidli
spread
world
contrast
mani
influenza
outbreak
viru
continu
circul
summer
month
northern
southern
hemispher
gener
produc
typic
syndrom
fever
headach
cough
malais
myalgia
case
mild
selflimit
howev
excess
hospit
mortal
infect
observ
infant
children
adult
younger
year
pregnant
women
children
particular
immunosuppress
particular
risk
avian
influenza
chapter
gener
infect
wild
bird
carri
viru
intestin
usual
made
sick
viru
howev
avian
influenza
highli
contagi
fatal
among
domest
bird
includ
chicken
turkey
duck
transmiss
human
rel
uncommon
despit
lack
immun
viru
human
outbreak
occur
contact
infect
bird
eg
domest
chicken
turkey
secret
excret
infect
bird
sar
emerg
addit
form
lifethreaten
atyp
pneumonia
first
detect
guangdong
provinc
china
late
major
outbreak
hong
kong
guangdong
singapor
toronto
vancouv
canada
diseas
caus
novel
coronaviru
chapter
incub
period
day
initi
sourc
infect
remain
uncertain
although
palm
civet
cat
chines
ferret
badger
harbor
coronaviru
greater
similar
human
sar
isol
worldwid
howev
ill
larg
nosocomi
diseas
health
care
worker
repres
signific
fraction
infect
individu
sar
character
insidi
onset
fever
chill
headach
cough
malais
dyspnea
radiolog
evid
pneumonia
although
upper
respiratori
symptom
uncommon
volumin
wateri
diarrhea
without
mucu
blood
develop
patient
sar
believ
princip
transmit
respiratori
droplet
current
treatment
support
antivir
agent
yet
prove
efficaci
sar
pneumonia
tend
resolv
slowli
spontan
usual
third
week
ill
howev
estim
casefat
rate
remain
approxim
sar
highli
contagi
lethal
transmiss
health
care
worker
document
isol
procedur
equip
appropri
sar
includ
standard
contact
airborn
isol
precaut
scrupul
hand
hygien
gown
dispos
glove
use
respir
eye
protect
suspect
case
sar
requir
notif
local
public
health
depart
center
diseas
control
prevent
physician
also
vigil
clue
pneumonia
relat
agent
bioterror
chapter
clue
includ
outbreak
sever
ill
pneumonia
multipl
otherwis
healthi
individu
isol
unusu
organ
patient
pneumon
ill
microorgan
like
associ
sever
pneumonia
bioterrorismrel
inhal
exposur
includ
b
anthraci
chapter
francisella
tularensi
chapter
pesti
chapter
inhal
anthrax
alway
indic
bioterror
threat
wherea
pneumon
plagu
tularemia
may
may
associ
bioterror
clinic
suspicion
pneumonia
prompt
standard
posteroanterior
later
chest
radiographi
although
pattern
infiltr
rare
establish
specif
microbiolog
etiolog
chest
film
use
provid
essenti
inform
distribut
extent
involv
well
potenti
pneumon
complic
mani
bacteri
pneumonia
result
local
alveolar
infiltr
consolid
even
though
pneumococc
pneumonia
classic
describ
lobar
distribut
pattern
multilobar
fig
bilater
bulg
fissur
sign
repres
lobar
fill
consolid
tradit
attribut
klebsiella
pneumonia
find
specif
observ
pneumonia
bacteria
even
bronchoalveolar
carcinoma
diffus
interstiti
alveolar
infiltr
suggest
viral
infect
cytomegaloviru
influenza
viru
rsv
l
pneumophila
enter
gramneg
pneumonia
particularli
neutropen
patient
diffus
pulmonari
infiltr
indistinguish
caus
acut
respiratori
distress
syndrom
diffus
alveolar
interstiti
infiltr
also
observ
patient
pneumocysti
jirovecii
pneumonia
chapter
relat
immun
suppress
acquir
immunodefici
syndrom
cavitari
lesion
often
indic
necrot
infect
relat
aureu
tuberculosi
certain
endem
fungi
coccidioid
immiti
aspergillu
speci
infect
immunocompromis
patient
chapter
anaerob
lung
infect
abscess
format
mediastin
adenopathi
widen
observ
inhal
anthrax
infect
chest
radiograph
provid
import
inform
potenti
infecti
complic
pneumonia
pleural
effus
chapter
occur
varieti
respiratori
infect
best
document
later
decubitu
view
comput
tomographi
ct
imag
thorax
discoveri
pleural
effus
greater
mm
thick
later
decubitu
film
locul
effus
prompt
thoracentesi
aid
identif
complic
parapneumon
effus
empyema
may
requir
definit
drainag
chapter
enlarg
mediastin
hilar
lymph
node
rare
acut
bacteri
infect
suggest
fungal
mycobacteri
infect
underli
lung
cancer
loss
volum
lung
segment
lobe
rais
suspicion
postobstruct
pneumonia
distal
endobronchi
lesion
caus
neoplasm
occult
foreign
bodi
broncholithiasi
consider
controversi
exist
appropri
microbiolog
evalu
patient
suspect
pneumonia
despit
intens
microbiolog
evalu
specif
organ
may
discov
half
patient
pneumonia
furthermor
patient
pneumonia
satisfactorili
respond
simpl
rel
nontox
antibiot
regimen
base
like
organ
caus
infect
thu
necess
document
precis
caus
process
remain
uncertain
debat
continu
need
perform
sputum
examin
gram
stain
everi
patient
communityacquir
pneumonia
american
thorac
societi
consensu
panel
recommend
sputum
gram
stain
cultur
obtain
primarili
organ
resist
usual
empir
treatment
regimen
suspect
use
sputum
contain
fewer
squamou
cell
leukocyt
per
lowpow
field
wellperform
gram
stain
may
reveal
singl
predomin
organ
encapsul
gramposit
cocci
pneumococci
small
pleomorph
gramneg
coccobacilli
haemophilu
howev
current
data
clearli
correl
gram
stain
find
result
cultur
alveolar
materi
larg
number
patient
communityacquir
pneumonia
nevertheless
sputum
examin
strongli
support
diagnosi
certain
specif
infect
includ
tuberculosi
acidfast
stain
endem
fungi
koh
prepar
p
jirovecii
methenamin
silver
fluoresc
antibodi
stain
legionella
speci
direct
fluoresc
antibodi
stain
case
communityacquir
pneumonia
gener
intent
sputum
gram
stain
examin
perform
detect
addit
unusu
pathogen
henc
expand
rather
narrow
initi
antibiot
therapi
often
adequ
sputum
specimen
obtain
gram
stain
interpret
may
equivoc
therefor
initi
therapeut
plan
must
base
like
pathogen
respons
pneumonia
unusu
drugresist
pathogen
suspect
sputum
specimen
sent
cultur
antibiot
therapi
initi
cultur
result
avail
compar
predomin
organ
observ
gram
stain
unfortun
sensit
specif
sputum
cultur
optim
roughli
antibiot
suscept
inform
isol
pathogen
organ
howev
use
epidemiolog
surveil
manag
patient
respond
initi
empir
therapi
cultur
normal
steril
bodi
fluid
blood
pleural
fluid
occasion
cerebrospin
fluid
csf
highli
specif
posit
approxim
one
fourth
patient
bacteri
pneumonia
demonstr
bacteremia
blood
drawn
cultur
administr
antibiot
patient
seriou
ill
attribut
pneumonia
diagnost
thoracentesi
perform
effus
larg
enough
aspir
safe
csf
examin
gener
reserv
patient
addit
sign
symptom
mening
irrit
chapter
abnorm
neurolog
examin
recommend
test
suspect
anthrax
includ
blood
cultur
chest
ct
scan
diagnosi
pneumon
plagu
blood
cultur
well
sputum
gram
stain
cultur
advis
tularem
pneumonia
cultur
obtain
blood
sputum
pharynx
cultur
extrem
virul
organ
undertaken
level
biocontain
laboratori
immunolog
techniqu
immunofluoresc
enzymelink
immunosorb
assay
antigen
detect
polymeras
chain
reaction
dna
hybrid
may
consid
specif
organ
strongli
suspect
clinic
ground
test
routin
indic
case
communityacquir
pneumonia
exampl
legionella
urinari
antigen
screen
acut
convalesc
serolog
evalu
may
help
l
pneumophila
pneumonia
suspect
chapter
legionella
urinari
antigen
test
may
underdiagnos
infect
caus
organ
legionella
serogroup
furthermor
judici
use
fungal
serolog
detect
endem
mycos
particularli
histoplasmosi
coccidioidomycosi
chapter
histoplasmosi
also
confirm
urinari
antigen
test
high
sensit
measur
aspergillu
galactomannan
antigen
serum
use
adjunct
diagnosi
invas
aspergillu
pneumonia
variou
immunocompromis
patient
bronchoscopi
lavag
immunostain
may
select
circumst
provid
enhanc
sensit
diagnosi
p
jirovecii
pneumonia
chapter
rapid
antigen
detect
test
avail
test
distinguish
influenza
b
prefer
test
current
recommend
epidemiolog
purpos
commun
also
help
direct
individu
therapi
rsv
antigen
detect
test
likewis
avail
rel
less
sensit
appli
sputum
adult
patient
varieti
assay
includ
polymeras
chain
reaction
pcr
special
antigen
test
avail
refer
laboratori
detect
diagnosi
novel
swine
influenza
avian
influenza
sar
coronaviru
invas
sampl
respiratori
secret
usual
necessari
patient
communityacquir
pneumonia
flexibl
fiberopt
bronchoscopi
protect
cathet
brush
bronchoalveolar
lavag
bal
sampl
larg
supplant
transtrach
transthorac
needl
aspir
bronchoscopi
indic
select
clinic
situat
delay
accur
diagnosi
may
seriou
consequ
immunocompromis
host
patient
whose
condit
worsen
despit
initi
antimicrobi
therapi
indic
bronchoscopi
set
appar
communityacquir
pneumonia
includ
either
lung
abscess
detect
chest
radiograph
chapter
evid
volum
loss
distal
consolid
suggest
endobronchi
obstruct
light
signific
morbid
potenti
mortal
pneumonia
appropri
measur
institut
reduc
possibl
lung
infect
import
often
neglect
intervent
includ
smoke
cessat
chapter
avoid
illicit
drug
chapter
excess
alcohol
chapter
may
impair
conscious
optim
patient
nutrit
statu
also
import
markedli
underweight
obes
patient
increas
risk
final
appropri
consist
use
vaccin
strongli
reduc
risk
pneumonia
appropri
patient
popul
chapter
current
pneumococc
vaccin
contain
purifi
capsular
polysaccharid
serotyp
pneumonia
respons
invas
pneumococc
infect
overal
vaccin
approxim
effect
prevent
death
invas
infect
accordingli
current
recommend
administ
patient
older
year
patient
younger
year
chronic
pulmonari
diseas
heart
diseas
diabet
mellitu
alcohol
chronic
liver
diseas
csf
leak
asplenia
patient
live
certain
set
includ
alaskan
nativ
highrisk
nativ
american
popul
patient
longterm
care
facil
current
pneumococc
vaccin
littl
toxic
limit
mainli
local
site
irrit
individu
gener
receiv
one
dose
vaccin
singl
revaccin
year
later
consid
receiv
vaccin
year
age
increas
risk
sever
pneumonia
pneumococc
vaccin
safe
administ
time
hospit
communityacquir
pneumonia
vaccin
chapter
also
consid
viral
influenza
chapter
although
usual
manifest
upper
respiratori
tract
infect
influenza
caus
pneumonia
immunocompet
immunosuppress
individu
commonli
influenza
may
precipit
subsequ
bacteri
infect
often
aureu
h
influenza
pneumonia
influenza
vaccin
develop
annual
current
influenza
strain
annual
revaccin
necessari
chapter
influenza
vaccin
estim
roughli
effect
prevent
mortal
relat
influenza
vaccin
consid
patient
older
year
resid
nurs
home
chronic
care
facil
person
chronic
pulmonari
cardiac
diseas
requir
ongo
medic
care
pregnant
women
second
third
trimest
influenza
season
health
care
worker
direct
patient
contact
weaken
viru
vaccin
administ
nasal
applic
caus
influenza
approv
healthi
peopl
year
year
age
pregnant
inactiv
vaccin
contain
kill
viru
administ
inject
approv
peopl
month
age
older
includ
healthi
peopl
peopl
chronic
medic
condit
pregnant
women
demonstr
efficaci
prevent
influenza
relat
complic
includ
pneumonia
contraind
influenza
vaccin
includ
allergi
raw
egg
thimeros
side
effect
gener
selflimit
includ
inject
site
sore
myalgia
mild
fever
malais
season
influenza
vaccin
lead
exacerb
asthma
vaccin
administ
fall
year
also
administ
local
epidem
oversight
agenc
increasingli
focus
object
measur
optim
care
communityacquir
pneumonia
particularli
hospit
set
although
recommend
evolv
sometim
vari
current
recommend
hospit
patient
communityacquir
pneumonia
undergo
assess
oxygen
initi
antibiot
therapi
emerg
depart
draw
blood
cultur
antimicrobi
initi
smoke
cessat
intervent
review
updat
immun
statu
expert
also
advis
chest
radiographi
time
admiss
use
biomark
bacteri
infect
level
procalcitonin
may
prove
help
determin
patient
avoid
immedi
antibiot
discontinu
initi
empir
antibiot
low
likelihood
bacteri
infect
microbiolog
etiolog
communityacquir
pneumonia
determin
approxim
case
diagnosi
may
take
day
two
clinician
must
institut
appropri
empir
therapi
base
like
agent
contribut
lung
infect
tabl
possibl
empir
therapi
initi
soon
possibl
diagnosi
establishedimmedi
outpati
set
emerg
depart
patient
hospit
empir
antimicrobi
therapi
base
sever
ill
inpati
outpati
set
broadli
cover
like
organ
common
bacteri
pathogen
pneumonia
chapter
h
influenza
chapter
howev
socal
atyp
pathogen
includ
pneumonia
c
pneumonia
legionella
speci
chapter
respect
primari
coinfect
agent
communityacquir
pneumonia
must
cover
empir
antibiot
regimen
therapi
narrow
later
relev
cultur
inform
obtain
current
guidelin
patient
stratifi
respect
treatment
initi
outpati
inpati
icu
set
presenc
underli
cardiopulmonari
diseas
modifi
factor
whether
treatment
patient
like
infect
drugresist
pneumonia
gramneg
enter
bacilli
pseudomona
aeruginosa
follow
guidelin
reduc
number
hospit
admiss
without
advers
affect
outcom
decis
admit
patient
hospit
must
made
clinic
ground
patient
effect
safe
manag
outpati
mildli
ill
younger
year
coexist
cardiopulmonari
diseas
malign
immun
compromis
renal
liver
signific
system
diseas
tabl
gener
outpati
mildli
ill
underli
cardiopulmonari
diseas
modifi
factor
usual
infect
pneumonia
pneumonia
c
pneumonia
h
influenza
respiratori
virus
legionella
speci
uncompl
outpati
case
manag
oral
advancedgener
macrolid
azithromycin
clarithromycin
better
toler
provid
better
coverag
haemophilu
speci
erythromycin
altern
doxycyclin
may
use
patient
intoler
macrolid
although
option
less
optim
increas
level
tetracyclin
resist
pneumonia
isol
outpati
underli
comorbid
eg
chronic
heart
lung
liver
renal
diseas
diabet
mellitu
alcohol
asplenia
immunosuppress
condit
drug
use
antibiot
within
past
month
exposur
child
daycar
center
higher
risk
drugresist
pneumonia
pneumonia
suffici
sever
warrant
admiss
comorbid
ill
stabl
compens
patient
treat
either
respiratori
fluoroquinolon
eg
moxifloxacin
gemifloxacin
levofloxacin
plu
macrolid
eg
highdos
amoxicillin
amoxicillinclavulan
prefer
altern
macrolid
prefer
eg
clarithromycin
extend
releas
mg
oral
day
least
day
azithromycin
mg
oral
day
follow
mg
oral
day
day
doxycyclin
mg
oral
twice
daili
least
day
presenc
comorbid
chronic
cardiopulmonari
liver
renal
diseas
diabet
mellitu
alcohol
malign
asplenia
immunosuppress
condit
drug
use
antimicrobi
prior
month
select
altern
agent
differ
class
respiratori
fluoroquinolon
oral
moxifloxacin
mgday
gemifloxacin
mgday
levofloxacin
mg
daili
least
day
eg
ceftriaxon
g
im
day
least
day
plu
macrolid
eg
azithromycin
mg
oral
day
follow
mg
oral
day
day
region
high
rate
infect
highlevel
mic
mg
ml
macrolideresist
streptococcu
pneumonia
consid
altern
agent
note
patient
without
comorbid
respiratori
fluoroquinolon
moxifloxacin
mgday
gemifloxacin
mgday
levofloxacin
mg
iv
day
follow
oral
least
day
total
eg
ceftriaxon
g
iv
daili
least
day
follow
g
im
daili
least
day
total
plu
macrolid
azithromycin
mg
iv
day
least
day
follow
mg
oral
day
total
least
day
cefotaxim
g
iv
everi
hr
ceftriaxon
g
iv
day
ampicillinsulbactam
g
iv
everi
hour
maximum
g
sulbactamday
day
plu
either
azithromycin
mg
iv
day
least
day
follow
mg
oral
day
total
least
day
respiratori
fluoroquinolon
eg
moxifloxacin
mgday
gemifloxacin
mgday
levofloxacin
mg
iv
daili
day
penicillinallerg
individu
respiratori
fluoroquinolon
eg
moxifloxacin
mgday
gemifloxacin
mgday
levofloxacin
mg
iv
daili
day
aztreonam
g
iv
everi
hr
day
recommend
pseudomona
speci
infect
concern
antipneumococc
antipseudomon
piperacillintazobactam
g
iv
everi
hr
cefepim
g
everi
hr
imipenem
mg
everi
hr
g
everi
hr
meropenem
g
iv
everi
hr
plu
either
ciprofloxacin
mg
iv
everi
hr
levofloxacin
mg
iv
everi
day
day
plu
aminoglycosid
eg
gentamicin
mgkgday
three
divid
dose
monitor
maintain
trough
level
lower
tobramycin
mgkgday
three
divid
dose
monitor
maintain
trough
level
lower
azithromycin
mg
iv
day
least
day
follow
mg
oral
day
day
plu
aminoglycosid
describ
antipneumococc
fluoroquinolon
ciprofloxacin
mg
iv
everi
hr
levofloxacin
mg
iv
everi
day
day
penicillinallerg
patient
use
aztreonam
g
iv
everi
hr
day
instead
communityacquir
methicillinresist
staphylococcu
aureu
consider
add
vancomycin
mgkg
everi
hr
monitor
maintain
trough
linezolid
mg
everi
hr
day
includ
ceftriaxon
cefpodoxim
cefuroxim
doxycyclin
altern
macrolid
tabl
region
high
incid
macrolideresist
pneumonia
altern
agent
use
pneumonia
treat
outpati
basi
patient
requir
care
monitor
certain
respond
first
hour
therapi
clinician
must
maintain
vigil
need
hospit
patient
deterior
fail
respond
initi
empir
therapi
patient
sever
respiratori
ill
signific
unstabl
uncompens
comorbid
ill
poor
initi
respons
otherwis
appropri
outpati
therapi
gener
admit
hospit
promptli
patient
requir
hospit
intens
care
treat
initi
either
intraven
respiratori
fluoroquinolon
levofloxacin
moxifloxacin
combin
intraven
plu
macrolid
patient
respiratori
insuffici
septicemia
shock
signific
multiorgan
dysfunct
without
need
mechan
ventilatori
support
requir
manag
icu
evalu
exclud
infect
p
aeruginosa
chapter
icu
admiss
also
consid
patient
exhibit
three
minor
criteria
sever
communityacquir
pneumonia
see
tabl
among
patient
sever
communityacquir
pneumonia
increas
risk
p
aeruginosa
infect
includ
patient
structur
lung
diseas
particularli
bronchiectasi
greater
mgday
previou
corticosteroid
therapi
neutropenia
malnutrit
previou
broadspectrum
antibiot
day
past
month
icu
patient
consid
risk
p
aeruginosa
infect
treat
initi
cefotaxim
ceftriaxon
ampicillinsulbactam
plu
either
azithromycin
respiratori
fluoroquinolon
moxifloxacin
levofloxacin
see
tabl
penicillinallerg
patient
respiratori
fluoroquinolon
aztreonam
reason
regimen
fluoroquinolon
monotherapi
consid
appropri
set
sever
communityacquir
pneumonia
icu
popul
consid
risk
p
aeruginosa
infect
combin
antipseudomon
therapi
use
includ
antipneumococc
antipseudomon
piperacillintazobactam
cefepim
imipenem
meropenem
plu
either
ciprofloxacin
levofloxacin
plu
aminoglycosid
azithromycin
communityacquir
methicillinresist
aureu
mrsa
infect
consider
vancomycin
linezolid
ad
regimen
therapi
suspect
proven
viral
infect
rel
limit
compar
bacteri
infect
earli
treatment
influenza
b
within
first
hour
symptom
oseltamivir
mg
oral
taken
twice
daili
day
zanamivir
two
inhal
mg
per
inhal
everi
hour
day
effect
reduc
symptom
durat
ill
chapter
agent
use
novel
swine
influenza
oseltamivir
may
also
activ
bird
flu
empir
antibiot
treatment
possibl
bacteri
superinfect
addit
influenza
includ
agent
effect
pneumonia
chapter
aureu
chapter
h
influenza
chapter
consider
amoxicillinclavulan
cefpodoxim
cefprozil
cefuroxim
respiratori
fluoroquinolon
would
appropri
pneumonia
caus
varicellazost
herp
simplex
viru
treat
parenter
acyclovir
mgkg
intraven
everi
hour
day
chapter
antivir
agent
establish
efficaci
rsv
adult
parainfluenza
viru
adenoviru
metapneumoviru
sar
coronaviru
hantaviru
treatment
larg
support
oxygen
ventil
therapi
necessari
patient
respond
empir
antibiot
regimen
first
day
therapi
gener
advis
alter
antibiot
program
first
hour
unless
patient
deterior
cultur
result
indic
altern
therapi
patient
initi
begun
parenter
therapi
may
switch
oral
regimen
afebril
temperatur
less
c
f
two
occas
hour
apart
demonstr
improv
cough
dyspnea
leukocytosi
patient
communityacquir
pneumonia
treat
least
day
afebril
least
hour
show
sign
clinic
instabl
discontinu
antibiot
therapi
accordingli
total
durat
antimicrobi
individu
patient
clinic
respons
initi
multiag
regimen
addit
macrolid
coverag
legionella
mycoplasma
frequent
deescal
sever
day
alon
legionella
urinari
antigen
mycoplasma
serolog
prove
neg
clinic
caveat
remain
howev
macrolid
may
still
requir
clinic
situat
strong
clinic
suspicion
legionella
persist
urinari
antigen
test
detect
organ
legionella
serogroup
furthermor
situat
caus
organ
isol
normal
steril
site
blood
pleural
fluid
antibiot
therapi
simplifi
direct
suscept
test
final
altern
clinic
diagnos
pneumonia
prove
caus
respiratori
symptom
cultur
remain
neg
first
hour
antibiot
therapi
may
safe
discontinu
treatment
failur
occur
approxim
patient
communityacquir
pneumonia
complic
occur
roughli
patient
adher
treatment
guidelin
describ
earlier
increas
likelihood
good
outcom
patient
respond
initi
empir
coverag
aggress
search
undertaken
detect
unusu
pathogen
altern
diagnos
pulmonari
embol
chapter
complic
pneumonia
complic
pleural
effus
chapter
empyema
lung
abscess
chapter
addit
diagnost
test
may
includ
chest
ct
scan
sampl
pleural
fluid
bronchoscopi
collect
respiratori
secret
brush
bal
fluid
microbiolog
analysi
even
patient
appear
respond
initi
antibiot
regimen
chest
radiograph
sign
resolv
slowli
period
week
clinic
sign
symptom
physician
must
document
abnorm
chest
radiograph
resolv
complet
case
led
format
fibrot
scar
usual
practic
includ
perform
repeat
radiographi
week
complet
antibiot
regimen
persist
abnorm
chest
radiograph
develop
recurr
pneumonia
similar
distribut
prompt
care
search
underli
endobronchi
obstruct
occult
neoplasm
chapter
foreign
bodi
bronchostenosi
broncholithiasi
followup
ct
scan
usual
prelud
formal
pulmonari
consult
consider
bronchoscopi
diagnost
test
although
microaspir
mechan
underli
case
pneumonia
clinician
occasion
confront
recurr
bacteri
pneumonia
patient
experienc
repeat
gross
aspir
oropharyng
content
patient
difficulti
swallow
relat
either
underli
neuromuscular
disord
alter
sensorium
result
medic
drug
alcohol
underli
neurolog
diseas
common
clinic
scenario
associ
recurr
aspir
pneumonia
includ
tracheobronchi
fistula
secondari
esophag
tracheal
malign
esophag
obstruct
relat
esophag
cancer
treatment
chapter
wide
varieti
neurolog
disord
includ
amyotroph
later
sclerosi
chapter
multipl
sclerosi
chapter
stroke
chapter
myopath
process
patient
sever
esophag
reflux
chapter
may
also
experi
signific
aspir
sleep
despit
appar
normal
deglutit
mechan
protect
reflex
wake
patient
neuromuscular
disord
tend
greater
difficulti
swallow
thin
liquid
materi
wherea
patient
obstruct
either
malign
benign
strictur
tend
greatest
difficulti
swallow
solid
food
aspir
pneumonia
tend
less
acut
manifest
usual
bacteri
pneumonia
onset
fever
dyspnea
purul
sputum
malais
system
symptom
includ
loss
appetit
evolv
number
day
physic
examin
chest
gener
reveal
coars
rhonchi
lower
lobe
depend
lung
region
diagnosi
aspir
pneumonia
reli
foremost
maintain
high
clinic
index
suspicion
recoveri
tracheal
secret
contain
food
particl
lipidladen
macrophag
strongli
support
diagnosi
patient
receiv
tube
feed
respiratori
secret
test
glucos
secret
normal
contain
low
level
glucos
altern
methylen
blue
similar
tracer
dye
ad
tube
feed
materi
confirm
presenc
aspir
addit
diagnost
modal
includ
use
cineradiograph
swallow
studi
thin
liquid
watersolubl
contrast
agent
confirm
aspir
event
radionuclid
imag
studi
may
also
document
aspir
adult
whose
neurolog
statu
preclud
cooper
fulli
cineradiograph
studi
overnight
esophag
ph
monitor
may
undertaken
individu
suspect
recurr
esophag
reflux
aspir
event
night
howev
except
sever
case
remain
difficult
predict
patient
gastroesophag
reflux
actual
experi
aspir
pneumonia
chest
radiograph
review
light
patient
probabl
posit
aspir
lower
lobe
particularli
superior
segment
right
lower
lobe
posterior
segment
upper
lobe
frequent
involv
howev
unilater
aspir
aspir
virtual
pulmonari
segment
report
depend
patient
posit
aspir
event
radiograph
appear
usual
reflect
parenchym
bronchopneumonia
process
pleural
involv
uncommon
initi
unless
aggress
anaerob
infect
present
nonresolv
inadequ
treat
aspir
pneumonia
result
lung
abscess
empyema
format
bronchoscopi
although
routin
necessari
confirm
presenc
aspir
recov
food
particl
lipidladen
macrophag
deriv
fat
present
aspir
food
bronchoscopi
bal
use
provid
quantit
count
aerob
bacteria
protect
specimen
brush
sampl
document
anaerob
organ
although
neg
cultur
exclud
presenc
anaerob
oropharyng
secret
contain
massiv
number
microorgan
count
aerob
bacteria
rang
anaerob
organ
high
per
millilit
saliva
accordingli
aspir
pneumonia
view
polymicrobi
infect
clinic
manifest
driven
predomin
aggress
organ
mixtur
oropharyng
colon
strongli
influenc
clinic
set
patient
dwell
time
aspir
outpati
versu
hospit
institut
otherwis
healthi
outpati
aggress
organ
pneumonia
aureu
h
influenza
may
also
present
contrast
oropharyng
secret
hospit
patient
resid
longterm
care
facil
includ
aerob
gramneg
bacteria
p
aeruginosa
anaerob
organ
major
consider
set
includ
anaerob
microaerophil
streptococci
bacteroid
speci
fusobacterium
nucleatum
prevotella
speci
cultur
sputum
tracheal
secret
probabl
document
mix
flora
empir
antibiot
therapi
initi
rapidli
diagnosi
aspir
pneumonia
made
regimen
modifi
later
cultur
inform
sputum
tracheal
secret
bronchoscop
sampl
avail
otherwis
healthi
individu
isol
aspir
pneumonia
relat
trauma
seizur
oversed
may
treat
initi
either
oral
amoxicillinclavulan
amoxicillin
mg
clavulan
acid
mg
oral
everi
hour
least
day
intraven
clindamycin
mg
intraven
iv
everi
hour
least
day
intraven
piperacillintazobactam
g
iv
everi
hour
least
day
depend
sever
ill
uncompl
mild
moder
aspir
pneumonia
elderli
patient
intraven
clindamycin
effect
less
expens
associ
lower
rate
posttreat
occurr
mrsa
patient
underli
chronic
diseas
intraven
piperacillintazobactam
g
iv
everi
hour
day
intraven
fluoroquinolon
cover
anaerob
moxifloxacin
mg
iv
day
day
consid
serious
ill
individu
particularli
patient
requir
intub
mechan
ventil
well
patient
experienc
aspir
hospit
longterm
care
set
coverag
must
extend
aerob
gramneg
bacteria
pseudomona
speci
treatment
consider
would
includ
extendedspectrum
inhibitor
combin
piperacillintazobactam
g
iv
everi
hour
day
ticarcillinclavulan
g
ticarcillin
g
clavulan
acid
iv
everi
hour
day
carbapenem
imipenem
mg
iv
everi
hour
day
intraven
clindamycin
mg
iv
everi
hour
also
ad
set
altern
intraven
clindamycin
given
combin
ciprofloxacin
mg
iv
everi
hour
day
aztreonam
g
iv
everi
hour
day
patient
concern
organ
high
level
antibiot
resist
p
aeruginosa
antipseudomon
ceftazidim
g
iv
everi
hour
day
cefepim
g
everi
hour
day
combin
antipseudomon
fluoroquinolon
ciprofloxacin
aminoglycosid
eg
gentamicin
mgkgday
three
divid
dose
iv
day
measur
drug
level
adjust
dose
achiev
trough
level
addit
extend
anaerob
coverag
clindamycin
consid
final
patient
known
suspect
harbor
mrsa
intraven
vancomycin
mgkg
everi
hour
iv
measur
drug
level
adjust
dose
achiev
trough
level
linezolid
mg
iv
everi
hour
day
ad
regimen
adequ
nutrit
concern
patient
multipl
episod
aspir
pneumonia
underli
neurolog
diseas
malign
endoscop
surgic
placement
gastrostomi
jejunostomi
feed
tube
consid
aid
provid
nutrit
fluid
medic
palliat
patient
greater
challeng
patient
continu
pneumonia
relat
aspir
saliva
sometim
around
cuf
endotrach
tracheostomi
tube
aggress
therapi
consid
appropri
ligat
submaxillari
parotid
salivari
duct
decreas
product
saliva
hospitalacquir
pneumonia
ventilatorassoci
pneumonia
health
careassoci
pneumonia
epidemiolog
hospitalacquir
pneumonia
ventilatorassoci
pneumonia
health
careassoci
pneumonia
repres
second
common
nosocomi
infect
unit
state
hospitalacquir
pneumonia
averag
increas
length
hospit
stay
day
addit
cost
per
patient
respons
one
fourth
icu
infect
half
antibiot
use
earlyonset
hospitalacquir
pneumonia
ventilatorassoci
pneumonia
defin
infect
occur
within
first
hospit
day
tend
caus
antibioticsuscept
bacteria
wherea
lateonset
infect
frequent
caus
multidrugresist
mdr
organ
tabl
associ
greater
morbid
mortal
overal
mortal
attribut
hospitalacquir
pneumonia
may
high
gramneg
bacteri
pneumonia
fairli
uncommon
previous
healthi
outpati
except
patient
impair
immun
underli
structur
lung
diseas
chronic
obstruct
pulmonari
diseas
howev
aerob
gramneg
bacilli
includ
p
aeruginosa
escherichia
coli
k
pneumonia
acinetobact
speci
play
major
role
patient
hospitalacquir
pneumonia
ventilatorassoci
pneumonia
health
careassoci
pneumonia
mani
case
polymicrobi
gramposit
agent
aureu
particularli
mrsa
strain
also
increasingli
common
frequenc
mdr
bacteria
vari
patient
popul
hospit
icu
local
use
antimicrobi
agent
routin
surveil
monitor
local
pathogen
drug
suscept
key
adjust
antibiot
use
appropri
p
aeruginosa
acinetobact
speci
stenotrophomona
maltophilia
burkholderia
cepacia
complex
particular
concern
organ
rapidli
becom
resist
multipl
class
antibiot
mdr
organ
commonli
found
patient
sever
underli
chronic
diseas
patient
health
careassoci
pneumonia
lateonset
hospitalacquir
pneumonia
ventilatorassoci
pneumonia
although
consider
emphasi
place
gramneg
bacteria
hospit
set
tradit
bacteri
pathogen
pneumonia
h
influenza
must
also
consid
potenti
caus
l
pneumophila
also
occasion
occur
nosocomi
infect
particularli
contamin
water
construct
hospitalacquir
pneumonia
ventilatorassoci
pneumonia
health
careassoci
pneumonia
often
first
suspect
demonstr
new
worsen
radiograph
infiltr
along
clinic
sign
infect
includ
fever
leukocytosi
purul
sputum
oxygen
may
also
worsen
gener
two
three
major
clinic
featur
fever
leukocytosi
purul
sputum
present
patient
acut
respiratori
distress
syndrom
howev
singl
clinic
factor
alon
prompt
addit
investig
microbiolog
cultur
patient
suspect
hospitalacquir
pneumonia
ventilatorassoci
pneumonia
health
careassoci
pneumonia
receiv
comprehens
histori
physic
examin
defin
sever
diseas
potenti
sourc
infect
chest
radiographi
essenti
determin
extent
pneumonia
particularli
whether
focal
multilobar
patient
without
new
evolv
radiograph
infiltr
sign
infect
may
purul
tracheobronch
chapter
may
requir
antibiot
therapi
clinic
sign
infect
present
arteri
blood
gase
complet
blood
count
electrolyt
liver
renal
function
also
evalu
blood
obtain
cultur
although
posit
minor
patient
institut
new
antibiot
whenev
possibl
lower
respiratori
tract
secret
obtain
cultur
patient
endotrach
aspir
bal
protect
specimen
brush
whenev
possibl
chang
antibiot
therapi
reliabl
gram
stain
help
direct
initi
empir
therapi
steril
cultur
lower
respiratori
patient
unstabl
evid
sepsi
high
suspicion
hospitalacquir
pneumonia
ventilatorassoci
pneumonia
health
careassoci
pneumonia
prompt
antibiot
therapi
requir
regardless
whether
bacteria
found
initi
microscop
examin
lower
respiratori
tract
sampl
delay
antimicrobi
therapi
increas
mortal
choic
initi
empir
therapi
base
sever
factor
includ
whether
pneumonia
earli
onset
whether
risk
factor
mdr
bacteri
infect
tabl
local
surveil
data
bacteri
preval
suscept
patient
suspect
hospitalacquir
ventilatorassoci
pneumonia
earlyonset
diseas
identifi
risk
factor
mdr
organ
initi
empir
therapi
includ
either
ceftriaxon
intraven
fluoroquinolon
levofloxacin
moxifloxacin
ciprofloxacin
ampicillinsulbactam
ertapenem
option
cover
pneumonia
treatment
tabl
empir
antibiot
treatment
hospitalacquir
pneumonia
ventilatorassoci
pneumonia
health
careassoci
pneumonia
initi
empir
antibiot
therapi
mandat
care
daili
reassess
patient
improv
first
hour
strong
consider
given
deescal
antibiot
therapi
base
cultur
result
lower
respiratori
cultur
remain
neg
patient
improv
extrapulmonari
site
infect
consid
addit
radiograph
imag
cultur
lung
pleura
site
may
help
total
durat
therapi
therefor
must
individu
gener
aminoglycosid
use
limit
day
overal
antibiot
therapi
short
day
patient
improv
patient
sluggish
improv
may
requir
day
therapi
sourc
pathogen
hospitalacquir
pneumonia
includ
environ
health
care
devic
transfer
microb
patient
staff
visitor
thu
scrupul
hand
hygien
essenti
reduc
infect
colon
plu
aspir
oropharyng
pathogen
leakag
secret
around
endotrach
tube
usual
rout
inocul
stomach
sinus
may
addit
site
harbor
pathogen
infect
biofilm
endotrach
tube
may
also
serv
import
reservoir
infect
light
aggress
measur
enforc
reduc
risk
hospitalacquir
pneumonia
ventilatorassoci
pneumonia
prevent
center
first
staff
educ
complianc
alcoholbas
hand
disinfect
must
use
patient
interact
addit
patient
document
mdr
organ
isol
reduc
risk
patient
crosscontamin
microbiolog
surveil
within
hospit
environ
also
necessari
identifi
mdr
organ
determin
antibiot
use
suscept
pattern
within
icu
intub
reintub
rate
monitor
reduc
feasibl
durat
mechan
ventil
minim
reduc
risk
ventilatorassoci
pneumonia
method
known
reduc
infect
rate
follow
chapter
ventilatorassoci
pneumonia
reduc
elev
head
patient
bed
daili
sedat
vacat
daili
assess
patient
readi
extub
peptic
ulcer
diseas
prophylaxi
deep
vein
thrombosi
prophylaxi
addit
continu
aspir
subglott
secret
safe
procedur
also
reduc
use
antimicrobi
agent
incid
ventilatorassoci
pneumonia
patient
risk
